期刊文献+

奎硫平合并西酞普兰治疗老年期抑郁症临床疗效观察 被引量:4

Observation of clinical curative effects on Quetiapine combined with Citalopram in the treatment of senile depression
下载PDF
导出
摘要 目的探讨奎硫平合并西肽普兰治疗老年抑郁症的临床疗效和安全性。方法将60例老年抑郁症患者随机分为两组,每组30例。对照组口服西肽普兰,研究组口服西肽普兰合并奎硫平。于治疗前及治疗后1、2、4周和8周评定汉密尔顿抑郁量表(HAMD)、老年抑郁量表(GDS)、药物副作用症状量表(TESS)。结果在治疗老年期抑郁症中,研究组在临床疗效、HAMD、GDS评分方面与对照组比较,差异有高度统计学意义(P<0.01),而在药物副作用方面差异无统计学意义(P>0.05)。结论老年抑郁症患者,合用喹硫平治疗起效快,疗效好,安全性高,适宜临床使用。 Objective To investigate the clinical curative effects and safety of Quetiapine combined with Citalopram in the treatment of senile depression. Methods Sixty patients with senile depression were randomly divided into two groups, with 30 patients in each group. The control group received the oral administration of Citalopram and the study group received the oral administration of Quetiapine combined with Citalopram. The Hamilton depression rating scale (HAMD), geriatric depression scale (GDS) and drug side effects symptom scale (TESS) were used for assessment before the treatment and 1, 2, 4 and 8 weeks after treatment. Results In the treatment of patients with senile depression, the study group was significantly different from the control group in the HAMD and GDS scores (P 〈 0.01), but not significantly different in the drug side effects (P 〉 0.05). Conclusion In the treatment of patients with senile depression, Quetiapine combined with Citalopram is fast, effective and safe, thereby suitable for clinical application.
出处 《中国医药导报》 CAS 2012年第19期76-77,共2页 China Medical Herald
基金 重庆市医疗特色专科建设项目(渝卫科教[2011]41号)
关键词 奎硫平 西肽普兰 老年抑郁症 Quetiapine Citalopram Senile depression
  • 相关文献

参考文献12

二级参考文献22

  • 1王祖訢.第三届国际难治性抑郁症会议概况[J].中华精神科杂志,1996,29(2):110-112. 被引量:8
  • 2Bougerol T,Scotto JC,Patris M,et al.Citalopram and fluoxetine in major depression-comparison of two clinical trials in a psychiatrist setting and in general practice[J].Clin Drug Investigation,1997,14:77-89.
  • 3Stahl SM.Placebo-controlled comparison of the selective serotonin re-uptake in higitors citalopram and sertraline[J].Biol Psychiatry,2000,48:894-901.
  • 4Noble S,Benfield P.Citalopram:a review of its pharmacology,clinical efficacy and tolerability in the treatment of depression[J].CNS Drugs,1997,8:410-431.
  • 5Adityanjee A,Schulz SC.Clinical use of quetiapine in disease states other than schizophrenia.J Clin Psychiatry,2002,63 (Suppl 13):32-38.
  • 6Vieta E,Mullen J,Brecher M,et al.Quetiapine monotherapy for mania associated with bipolar disorder:combined analysis of two international,double-blind,randomised,placebo-controlled studies.Curr Med Res Opin,2005,21 (6):923-934.
  • 7Sokolski KN,Denson TF.Adjunctive quetiapine in bipolar patients partially responsive to lithium or valproate prog neuropsycho-pharmacol.Biol Psychiatry,2003,27 (5):863-866.
  • 8Bowden CL,Grunze H,Mullen J,et al.A randomized,doubleblind,placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.J Clin Psychiatry,2005,66(1):111-121.
  • 9Meltzer HY.The metabolic consequences of long-term treatment with olanzapine,quetiapine and risperidone:are there differences.Int J Neuropsychopharmacol,2005,8(2):153-156.
  • 10Calabrese JR,Keck PE Jr,Macfadden W,et al.A randomized,double-blind,placebo-controlled trial of quetiapine in the treatment of bipolar Ⅰ or Ⅱ depression.Am J Psychiatry,2005,162(7):1351-1360.

共引文献196

同被引文献24

引证文献4

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部